Glytec

Glytec

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.glytec.com

Last Round

Growth Equity

Jun 17, 2025

Total Funding Raised

$65.27M

Momentum Score

25 /100

Company Overview

Glytec is a healthcare technology company that provides an AI-powered, cloud-based platform for insulin management, primarily for hospital settings. Founded in 2006 by software developer Robby Booth and diabetologist Dr. Bruce Bode, the company developed the first FDA-cleared software for glucose management. Its flagship product, Glucommander®, is a Software-as-a-Service (SaaS) solution that integrates with electronic health records (EHRs) to provide personalized insulin dosing recommendations, clinical decision support, and analytics. The platform is designed to improve patient safety by reducing hypoglycemia, shorten hospital stays, and streamline clinical workflows for diabetes care. Trusted by over 400 hospitals, Glytec aims to set the standard for glycemic management and support healthcare systems in meeting new quality measures from the Centers for Medicare & Medicaid Services (CMS).

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, EHR & EMR, Healthcare Analytics, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

insulin management softwareglycemic managementFDA-cleared softwaredosing decision supportclinical decision supportCDSSeGMSpersonalized insulin dosingGlucommanderSoftware as a Medical DeviceSaMDEHR integrationIV insulin managementpatient safety softwarehospital SaaSdigital therapeuticsglycemic analyticsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Glytec Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Glytec Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJun 17, 2025
Series BApr 26, 2021
DebtApr 26, 2021
Series ASep 19, 2011

Key People

Founding team and executive leadership

Coy Gupta

CTO Head Of AI

Executive Team

Erik Eaker

Chief Operating Officer

Executive Team

Glytec Investors

Notable investors and investment history

InvestorRounds
Hayfin Capital ManagementGrowth Equity
Savitr CapitalSeries B, Growth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2026

    Yamaha Motor Co. establishing U.S. headquarters in Kennesaw, Georgia.

  • Mar 19, 2026

    Moving global headquarters to the Wildwood Center.

Glytec Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Glytec Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Glytec's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range87
Year Founded2006
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.